Molecular characterisation of TP53 mutated squamous cell carcinomas of the lung to identify putative targets for therapy

Personalised cancer treatment depends on identification of therapeutically relevant biological subgroups of patients for assessing effect of treatment and to discover new therapeutic options. By analyses in heterogeneous patient populations, the effects may be lost in noise. Squamous cell carcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Haakensen, Vilde D., Khadse, Anand, Sandhu, Vandana, Halvorsen, Ann Rita, Solberg, Steinar K., Jørgensen, Lars H., Brustugun, Odd Terje, Kure, Elin H., Helland, Åslaug
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Tumor Markers and Signatures
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540694/
https://www.ncbi.nlm.nih.gov/pubmed/32468587
http://dx.doi.org/10.1002/ijc.33121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540694/
https://www.ncbi.nlm.nih.gov/pubmed/32468587
http://dx.doi.org/10.1002/ijc.33121

Ejemplares similares